Orexigen Therapeutics, Inc. (NASDAQ:OREX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.

Recs

0
Player Avatar phatchips767 (< 20) Submitted: 6/27/2012 8:46:53 PM : Outperform Start Price: $5.53 OREX Score: -9.09

porto. likedded it.

Featured Broker Partners


Advertisement